January 9, 2018
The FDA granted breakthrough therapy designation to lenvatinib mesylate in combination with pembrolizumab for the treatment of patients with advanced or metastatic renal…
In the Journals Plus
January 4, 2018
The cancer mortality rate dropped 1.7% from 2014 to 2015, continuing a decades-long decline reaching 26% since 1991, according to Cancer Statistics 2018, the American…
December 31, 2017
Five ASCO members have been elected to the society’s board of directors to fill existing vacancies. The new members will serve 4-year terms beginning in June 2018.